Stock Information

• Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript
  Mon, Mar 2, 2026 9:17 PM
• Zymeworks Inc (NASDAQ:ZYME) Posts Wider Q4 Loss Despite Strategic Progress and Royalty Deal
  Mon, Mar 2, 2026 12:24 PM
• Zymeworks Inc. 2025 Q4 - Results - Earnings Call Presentation
  Mon, Mar 2, 2026 9:02 AM
• Earnings Scheduled For March 2, 2026
  Mon, Mar 2, 2026 7:11 AM
• Zymeworks And Royalty Pharma Enter Into $250M Funding From Royalty-backed Note With Repayments Due From 30% Of Worldwide Tiered Royalties On Ziihera (Zanidatamab-hrii) Owed To Zymeworks From Jazz Pharmaceuticals And BeOne Medicines
  Mon, Mar 2, 2026 7:09 AM
• Earnings Breakdown: Zymeworks Q4
  Mon, Mar 2, 2026 7:06 AM
• Zymeworks Q4 2025 EPS $(0.55) Misses $(0.42) Estimate, Sales $2.515M Miss $13.576M Estimate
  Mon, Mar 2, 2026 7:04 AM
• Zymeworks Secures $250 Million From Royalty Pharma In Royalty-Backed Deal Tied To Ziihera Sales, Pledges 30% Of Future Ziihera Royalties For Repayment
  Mon, Mar 2, 2026 7:03 AM
• A Look Ahead: Zymeworks's Earnings Forecast
  Fri, Feb 27, 2026 2:01 PM
• Jazz Pharmaceuticals: Relief Rally On 2026 Oxybate Franchise's Outlook
  Thu, Feb 26, 2026 8:19 AM

Financial data not available